IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kite Pharma Inc

CUSIP: 49803L959 | 6 institutional holders

Quarters

Q3 2017Q2 2017Q1 2017Q4 2016Q3 2016
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile